Library

Home > Library

Search results : stock return

Bidenomics 2.0: trade, taxation, and technology

2024-02-14This ebook delves into key financial topics and stock market investment articles.

This AYA analytic ebook delves into the macroeconomic and technological aspects of Bidenomics from mid-2020 to present. This ebook comprises 4 main parts. The first part explains the pre-Biden Trump economic policy reforms in t...+See More
Bidenomics

2022-09-21This ebook delves into key financial topics and stock market investment articles.

This AYA analytic ebook delves into the macroeconomic and technological aspects of Bidenomics from mid-2020 to present. This ebook comprises 3 main parts. The first part explains the pre-Biden Trump economic policy reforms in t...+See More
Key motifs in the merry medley of Trump economic reform 2016-2020

2020-06-06This ebook delves into key financial topics and stock investment memes blog posts and essays.

This ebook offers the key motifs in the merry medley of Trump economic reform 2016-2020: (1) Federal Reserve monetary policy decisions and interest rate adjustments in response to inflationary fluctuations, economic output g...+See More
Algorithmic system for dynamic conditional asset return prediction and fintech network platform automation

2018-10-11The current invention pertains to the novel, non-obvious, and applicable design and development an algorithmic system for dynamic conditional asset return prediction and fintech network platform automation.

The current invention pertains to the novel, non-obvious, and applicable design and development an algorithmic system for dynamic conditional asset return prediction and fintech network platform automation.+See More
1

Blog+More

Stock Synopsis: With a new Python program, we use, adapt, apply, and leverage each of the mainstream Gemini Gen AI models to conduct this comprehensive fundamental analysis of Nvidia (U.S. stock symbol: $NVDA).

Peter Prince

2025-09-24 09:49:53 Wednesday ET

Stock Synopsis: With a new Python program, we use, adapt, apply, and leverage each of the mainstream Gemini Gen AI models to conduct this comprehensive fundamental analysis of Nvidia (U.S. stock symbol: $NVDA).

Stock Synopsis: With a new Python program, we use, adapt, apply, and leverage each of the mainstream Gemini Gen AI models to conduct this comprehensive fund

+See More

Americans continue to keep their financial New Year resolutions.

Jonah Whanau

2019-01-15 13:35:00 Tuesday ET

Americans continue to keep their financial New Year resolutions.

Americans continue to keep their financial New Year resolutions. First, Americans should save more money. Everyone needs a budget to ensure that key paychec

+See More

Thomas Piketty connects the dots between economic growth and inequality worldwide with long-term global empirical evidence.

Chanel Holden

2023-05-28 10:24:00 Sunday ET

Thomas Piketty connects the dots between economic growth and inequality worldwide with long-term global empirical evidence.

Thomas Piketty connects the dots between economic growth and inequality worldwide with long-term global empirical evidence. Thomas Piketty (2017) &nbs

+See More

A brief biography of Andy Yeh

Andy Yeh Alpha

2020-11-22 11:30:00 Sunday ET

A brief biography of Andy Yeh

A brief biography of Andy Yeh Andy Yeh is responsible for ensuring maximum sustainable member growth within the Andy Yeh Alpha (AYA) fintech network pla

+See More

Saudi Aramco unveils the financial secrets of the most profitable corporation in the world.

Jacob Miramar

2019-04-13 14:28:00 Saturday ET

Saudi Aramco unveils the financial secrets of the most profitable corporation in the world.

Saudi Aramco unveils the financial secrets of the most profitable corporation in the world. In its recent public bond issuance prospectus, Aramco offers the

+See More

The recent Bristol-Myers Squibb acquisition of American Celgene is the $90 billion biggest biotech deal in history.

Jacob Miramar

2019-01-10 17:31:00 Thursday ET

The recent Bristol-Myers Squibb acquisition of American Celgene is the $90 billion biggest biotech deal in history.

The recent Bristol-Myers Squibb acquisition of American Celgene is the $90 billion biggest biotech deal in history. The resultant biopharma goliath would be

+See More